List view / Grid view
5 July 2018 | By Tecan
Researchers at the University Hospital of Salzburg's EB House Austria are using a Tecan Spark® multimode reader to investigate epidermolysis bullosa (EB), a rare inherited disease that causes the skin to become ‘as fragile as a butterfly’s wings’, blistering in response to friction or trauma...
28 June 2018 | By Hyglos
The rapid ENDOZYME® II GO assay is the latest member of bioMérieux’s ENDONEXT™ range of endotoxin detection assays based on sustainable recombinant horseshoe crab Factor C (rFC). The new assay caters to two important needs: efficiency and consistency...
bioMérieux launches ENDOZYME® II GO, an innovative test for the detection of endotoxins in pharmaceutical microbiology control
27 June 2018 | By bioMérieux
bioMérieux, a world leader in the field of industrial microbiological control, announces the launch of ENDOZYME® II GO, a new endotoxin test in the bioMérieux ENDONEXT™ range of recombinant horseshoe crab Factor C (rFC) assays.
23 May 2018 | By European Pharmaceutical Review
Researchers have developed a highly specific apoptosis assay designed for immunofluorescence microscopy analysis of fixed core needle biopsy specimens...
13 May 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
Technique measuring the cccDNA marker may allow earlier detection of hepatocellular carcinoma in patients...
26 April 2018 | By Kevin L Williams - bioMerieux
Limulus amebocyte lysate (LAL) users, compendial experts and regulators are still orienting themselves to the recombinant factor C (rFC) assay. Changes to compendial standards do not occur overnight and, for now, users willing to change must perform the alternative validation procedure USP .
17 February 2018 | By Dr Zara Kassam (European Pharmaceutical Review)
A technique which allows the continuous production and collection of a cell has been developed removing the limit on the number of cells that can be grown in a culture dish...
2 January 2018 | By Henry Havel
At least some degree of solubility in water is necessary for active ingredients in pharmaceutical products to be effective in vivo. However, as efforts to discover and synthesise new active ingredients are pursued by industrial and academic medicinal chemists, achieving sufficient aqueous solubility can often be a significant limitation to…
Whitepaper: Sensitive and flexible bacterial endotoxin testing with the EndoZyme® II Recombinant Factor C Assay using the Synergy™ HTX Microplate Reader
13 December 2017 | By Hyglos
This article covers how the EndoZyme II assay is established, optimised and validated using the SynergyTM HTX Multi-Mode Microplate Reader with Gen5TM software...
21 September 2017 | By Tecan
Tecan’s innovative Spark® multimode reader can now provide walkaway processing of up to 50 assay plates per run with the addition of the new Spark-Stack™ integrated microplate stacker...
5 July 2017 | By Niamh Marriott (European Pharmaceutical Review)
By 2040, there will be over 1.2 million people living with dementia in England and Wales (an increase of 57% from 2016), due to increased life expectancy...
22 June 2017 | By
Head of Drug Discovery at the Fraunhofer Institute for Molecular Biology and Applied Ecology
12 June 2017 | By William Meurer (Michigan Medicine)
Diagnostic tests can help identify disease and disease probability in patients, leading to earlier treatment, but what’s the real cost?